HRAS and diabetes mellitus: In diabetes H-Ras is activated, oxidative stress, including superoxide levels are elevated in the retina and its endothelial cells, and the therapies that inhibit the development of retinal histopathology in diabetes also inhibit Ras activation and superoxide accumulation [1,15,16].